Released on = August 4, 2006, 2:47 am

Press Release Author = PharmaPromo

Industry = Pharmaceuticals

Press Release Summary = Pharmapromo launches a reference website on the generic
medication fluoxetine, aimed at both consumers and pharmaceutical and healthcare
industry professionals.

Press Release Body =
BARCELONA, Spain - Friday, August 4th 2006 - PharmaPromo, the owner of a major
network of over 250 websites dedicated to generic medications, today announced the
launch of www.fluoxetine.com. This unique medication website provides highly
relevant and comprehensive information on the generic drug fluoxetine, more commonly
known by its brand names Prozac®, Prozac Weekly® and Sarafem®.

Fluoxetine is used to treat depression and mental health conditions that currently
affect over 15 million Americans. Over the last decade the global antidepressant
medication market has seen an extraordinary growth and currently holds the position
of the third leading drug class by prescription revenue. However, with only ten
leading drugs on the market generating global sales of $14 billion in 2004 and nine
out of these ten facing loss of patents between 2006 and 2011, the dynamics of this
market are set to undergo considerable changes with very few blockbuster drugs
entering the market. As generic competition intensifies, companies need to carefully
re-examine their strategies if they wish to protect their market share.

Fluoxetine.com is set to become the leading reference point for both consumers and
pharmaceutical industry professionals seeking reliable and accurate information in a
market that is facing new challenges. It provides extensive product information and
up-to-date resources, together with exclusive insider industry news on which
companies and organizations are playing an important part in its research,
development, production and promotion.

For consumers, this website provides access to relevant information and covers key
topics regarding depression, obsessive-compulsive disorder, eating disorders such as
bulimia nervosa, premenstrual dysphoric disorder and panic disorder. For them this
medication provides a way of controlling their illness to prevent it from burdening
their daily lives. Consumers are progressively being presented with a greater
variety of medications that suit varying needs, both medically and economically.
Fluoxetine.com is their source of accurate and detailed information about what is
available on the market (either in its branded form or generic version).

From a pharmaceutical company or health organization stand point the website offers
companies the opportunity to develop their corporate identity and extend their
customer reach as it continues to attract an increasing amount of regular and highly
targeted users. All visitors have the opportunity to take part in open discussion
forums and share their own knowledge and experiences with other consumers. This
hands-on approach by regular patients and pharmacists who have had experience using
fluoxetine will create an expansive community and interactive meeting point.

About PharmaPromo:
PharmaPromo is one of several online business divisions provided by the Anakena
Group, a European company located in Barcelona, Spain. Founded in April 1999, the
company is dedicated to developing innovative Internet strategies for specific
niches including the pharmaceutical market. It focuses on providing a unique service
for patients, and offer leading pharmaceutical companies, manufacturers, PBMs and
healthcare professionals the most competitive solutions for strengthening the reach
and frequency of their corporate message, as well as securing their company's online
presence via a highly-targeted advertising platform. The completion of
fluoxetine.com adds further depth to the PharmaPromo project - covering the
top-selling worldwide drugs and principal therapeutic areas - and predicts the
completion of its redevelopment project by September 2006. For additional
information please visit our website at www.pharmapromo.com.

Editorial note: Prozac®, Prozac Weekly® and Sarafem® are registered trademarks of
Eli Lilly and Company.


Web Site = http://www.fluoxetine.com

Contact Details = Media Contact:
Louise Wanstall
Public Relations Officer
Tel: + 34 93 272 0360
Email: louise@pharmapromo.com
Skype: pharmahelp

Business Contact:
Richard Cottrell
B2B Development Manager
C/ Mallorca 235 3º 2ª
08008 Barcelona, Spain
Tlf: +34 93 183 3330
Fax: +34 93 487 98 10
Email: richard@pharmapromo.com
Skype: pharmapromo